Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-08-03 4:38 pm Unchanged | 2026-08-03 | 13D | TRANSCODE THERAPEUTICS INC RNAZ | CK Life Sciences Intl (Holdings) Inc | 14,134,481 83.900% | 0 (Unchanged) | Filing History |
| 2026-07-27 4:15 pm Purchase | 2026-07-27 | 13D | TRANSCODE THERAPEUTICS INC RNAZ | CK Life Sciences Intl (Holdings) Inc | 14,134,481 83.900% | 13,834,441![]() (+4610.87%) | Filing History |
| 2026-07-23 4:15 pm Purchase | 2026-07-23 | 13D | TRANSCODE THERAPEUTICS INC RNAZ | CK Life Sciences Intl (Holdings) Inc | 300,040 9.900% | 216,755![]() (+260.26%) | Filing History |
| 2026-07-17 4:15 pm Unchanged | 2026-07-17 | 13D | TRANSCODE THERAPEUTICS INC RNAZ | CK Life Sciences Intl (Holdings) Inc | 83,285 8.800% | 0 (Unchanged) | Filing History |
| 2025-10-28 5:39 pm Unchanged | 2025-10-27 | 13D | TRANSCODE THERAPEUTICS INC RNAZ | CK Life Sciences Intl (Holdings) Inc | 83,285 9.100% | 0 (Unchanged) | Filing History |
| 2025-10-16 4:05 pm Purchase | 2025-10-08 | 13D | TRANSCODE THERAPEUTICS INC RNAZ | CK Life Sciences Intl (Holdings) Inc | 83,285 9.100% | 83,285![]() (New Position) | Filing History |
